Title |
Use of Selective Serotonin Reuptake Inhibitors Antidepressants and Bleeding Risk in Breast Cosmetic Surgery
|
---|---|
Published in |
Aesthetic Plastic Surgery, April 2013
|
DOI | 10.1007/s00266-013-0111-7 |
Pubmed ID | |
Authors |
Filipe Volpe Basile, Antonio Roberto Basile, Vinicius Volpe Basile |
Abstract |
Selective serotonin reuptake inhibitors (SSRIs) are the most common antidepressant prescribed currently. Data regarding SSRI use among plastic surgery patients may differ between different populations, but the incidence could be as high as 10 %. It is known that SSRIs decrease platelet serotonin storage and platelet function, and their association with postsurgical bleeding in mastectomy patients and orthopedic surgery patients is well established. An increased risk of postsurgical bleeding among plastic surgery patients may have important clinical implications, but this has not been evaluated to date. The authors therefore conducted a hospital-based study with prospectively collected data to examine the association between the use of SSRIs and postsurgical bleeding. To the authors' knowledge, this is the first study to evaluate the effects of SSRIs on bleeding risk in the breast cosmetic surgery population. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 6 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 30 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 20% |
Student > Bachelor | 5 | 17% |
Student > Master | 3 | 10% |
Student > Doctoral Student | 2 | 7% |
Student > Ph. D. Student | 2 | 7% |
Other | 3 | 10% |
Unknown | 9 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 43% |
Psychology | 4 | 13% |
Business, Management and Accounting | 1 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Neuroscience | 1 | 3% |
Other | 0 | 0% |
Unknown | 10 | 33% |